AstraZeneca (AZNCF) Institutional Ownership $126.02 +0.56 (+0.45%) (As of 11/19/2024 ET) Add Compare Share Share Ownership Stock AnalysisChartDividendFinancialsHeadlinesOwnershipSEC FilingsShort Interest Institutional Ownership Changes (13F Filings) for AstraZeneca (OTCMKTS:AZNCF)CurrentInstitutional OwnershipPercentage40.87%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$5.30MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$6.97M Get AZNCF Insider Trade Alerts Want to know when executives and insiders are buying or selling AstraZeneca stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data AZNCF Institutional Buying and Selling by Quarter Ad Darwin2025 AI Stock Picks: 2 Hidden Gems Under $10/ShareThe AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.👉[Click here to get your FREE report delivered instantly!] AstraZeneca Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails10/22/2024 Eagle Bay Advisors LLC1,001$156K0.1%N/A0.000% 10/9/2024 Boston Common Asset Management LLC262,273$40.77M1.1%-9.2%0.000% 7/8/2024 Boston Common Asset Management LLC288,790$45.11M1.2%-3.6%0.000% 5/16/2024 Kennedy Capital Management LLC37,554$5.07M0.1%N/A0.000% 1/9/2024 Boston Common Asset Management LLC301,010$40.58M0.9%-2.8%0.000% 10/11/2023 Boston Common Asset Management LLC309,762$41.97M1.0%-1.1%0.000% 7/24/2023 Boston Common Asset Management LLC313,065$44.88M1.0%+15.5%0.000% 5/17/2023 Boston Common Asset Management LLC271,130$37.65M0.8%N/A0.000% 5/1/2023Vigilant Capital Management LLC647$90K0.0%-16.2%0.000% (Data available from 1/1/2016 forward) AZNCF Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of AZNCF shares? During the previous two years, the following institutional investors and hedge funds held shares of AstraZeneca shares: Boston Common Asset Management LLC ($40.77M), Kennedy Capital Management LLC ($5.07M), and Eagle Bay Advisors LLC ($156K), Vigilant Capital Management LLC ($90K).Learn more on AZNCF's institutional investors. What percentage of AstraZeneca stock is owned by institutional investors? 40.87% of AstraZeneca stock is owned by institutional investors. Learn more on AZNCF's institutional investor holdings. Which institutional investors have been buying AstraZeneca stock? The following institutional investors have purchased AstraZeneca stock in the last 24 months: Boston Common Asset Management LLC ($313.07K), Kennedy Capital Management LLC ($37.55K), and Eagle Bay Advisors LLC ($1.00K). How much institutional buying is happening at AstraZeneca? Institutional investors have bought a total of 351,620 shares in the last 24 months. This purchase volume represents approximately $49.33M in transactions. Which AstraZeneca major shareholders have been selling company stock? The following institutional investors have sold AstraZeneca stock in the last 24 months: Boston Common Asset Management LLC ($49.47K), and Vigilant Capital Management LLC ($125.00). How much institutional selling is happening at AstraZeneca? Institutional investors have sold a total of 49,590 shares in the last 24 months. This volume of shares sold represents approximately $7.44M in transactions. Related Companies Alvotech Institutional Ownership This page (OTCMKTS:AZNCF) was last updated on 11/20/2024 by MarketBeat.com Staff From Our PartnersAmazon's $150B Data Center Bet—What It Means for Uranium InvestorsAmazon is placing a massive bet on nuclear energy to power its $150 billion data center expansion. With dem...The Bull Report | SponsoredBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredJD Vance Predicts: Wall Street vs. Trump & Your MoneyTrump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purpose...Priority Gold | SponsoredTesla Execs are Freaking OutIt’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands...Angel Publishing | SponsoredBuffett Dumps $982 Million in BofA Stock—What Does He Know?Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track reco...Genesis Gold Group | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AstraZeneca PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share AstraZeneca With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AZNCF Stock Alerts